Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kenvue Inc. Common Stock
(NY:
KVUE
)
21.93
+0.48 (+2.24%)
Official Closing Price
Updated: 7:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Kenvue Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Breaking Down Kenvue: 8 Analysts Share Their Views
February 07, 2025
Via
Benzinga
Kenvue (KVUE) Q4 2024 Earnings Call Transcript
February 06, 2025
KVUE earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Kenvue's Q4 Sales Miss, Margins Improve
February 06, 2025
Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and Beauty segment.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For February 6, 2025
February 06, 2025
Via
Benzinga
All It Takes Is $3,000 Invested in Each of These 3 Ultra-Reliable Dividend King Stocks to Help Generate Over $300 in Passive Income in 2025
February 04, 2025
Via
The Motley Fool
Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?
February 01, 2025
Via
The Motley Fool
A Look Into Kenvue Inc's Price Over Earnings
January 30, 2025
Via
Benzinga
What Analysts Are Saying About Kenvue Stock
January 15, 2025
Via
Benzinga
Peering Into Kenvue's Recent Short Interest
December 17, 2024
Via
Benzinga
Critical Insights From Kenvue Analyst Ratings: What You Need To Know
December 12, 2024
Via
Benzinga
These Dividend Stocks Fell Between 1% and 20% in 2024. Here's Why They Are Too Cheap to Ignore and Worth Buying in 2025.
January 21, 2025
Via
The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
January 17, 2025
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.
Via
The Motley Fool
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company
January 17, 2025
Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential...
Via
Benzinga
10 One Decision Stocks To Buy Now
January 15, 2025
The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats.
Via
Talk Markets
Topics
Stocks / Equities
10 Conservative Retirement Income Stocks To Buy Now
December 29, 2024
Conservative retirement investing is all about creating passive income with quality securities, held for the long-run.
Via
Talk Markets
Topics
Retirement
Stocks / Equities
Exposures
Pension
How Is The Market Feeling About Kenvue?
November 20, 2024
Via
Benzinga
In-Depth Technical Analysis of KENVUE INC.
November 18, 2024
With a solid technical rating of 8 out of 10, KENVUE INC (NYSE:KVUE) is showing strong indications of a possible breakout.
Via
Chartmill
3 Dividend-Paying Value Stocks to Buy Even If There's a Stock Market Sell-Off in 2025
December 29, 2024
Investing by equal parts in these three dividend stocks produces an average yield of 3%.
Via
The Motley Fool
A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now
December 23, 2024
Via
The Motley Fool
Coca-Cola cs. Procter & Gamble: Which Is the Better Dow Dividend King Stock to Buy Before the End of the Year?
December 08, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months.
December 04, 2024
These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years.
Via
The Motley Fool
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
November 08, 2024
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued.
Via
Benzinga
Exposures
Product Safety
Is Kenvue Stock a Buy Now?
October 25, 2024
The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.
Via
The Motley Fool
10 Analysts Have This To Say About Kenvue
October 22, 2024
Via
Benzinga
Kenvue (KVUE) Q3 2024 Earnings Call Transcript
November 07, 2024
KVUE earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales
November 07, 2024
Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in Skin Health and Beauty.
Via
Benzinga
This Big New Development Could Be Bullish for Kenvue Stock
October 30, 2024
Can tinkering around the edges actually make this stock more attractive?
Via
The Motley Fool
3 Dividend Stocks to Double Up on Right Now
October 27, 2024
While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio.
Via
The Motley Fool
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy.
October 26, 2024
Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock.
Via
The Motley Fool
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months
October 26, 2024
An activist investor is taking a stake in Kenvue stock.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.